IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,888,500 | -14.5% | 50,000 | 0.0% | 0.20% | -14.7% |
| Q3 2022 | $2,210,000 | +19.4% | 50,000 | 0.0% | 0.23% | +10.0% |
| Q2 2022 | $1,851,000 | -29.6% | 50,000 | -29.6% | 0.21% | -18.9% |
| Q1 2022 | $2,630,000 | +14.8% | 71,000 | -5.3% | 0.26% | +70.4% |
| Q4 2021 | $2,291,000 | -8.9% | 75,000 | 0.0% | 0.15% | -14.1% |
| Q3 2021 | $2,516,000 | -15.9% | 75,000 | 0.0% | 0.18% | -12.8% |
| Q2 2021 | $2,992,000 | -11.3% | 75,000 | 0.0% | 0.20% | -13.6% |
| Q1 2021 | $3,372,000 | +30.1% | 75,000 | +17.2% | 0.24% | -54.4% |
| Q1 2016 | $2,592,000 | -37.5% | 64,000 | -4.5% | 0.52% | -17.9% |
| Q4 2015 | $4,149,000 | – | 67,000 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |